Newsletter Signup | Join Community
Neoadjuvant Keytruda, Tecentriq, and Sacituzumab Govitecan (IMMU-132) are promising TNBC treatment advances.
Stay Current With Triple-Negative Breast Cancer Treatment Advances & Connect with Others
Dr. Bhuvaneswari Ramaswamy of the OSU Arthur G. James Cancer Hospital answers frequently asked questions about TNBC
Iniparib Promising in Metastatic Triple-negative Breast Cancer
Obesity Linked with Triple-Negative Breast Cancer
Erbitux May Increase Response Rates in Metastatic Triple-Negative Breast Cancer.
Triple Negative Breast Cancer Linked with Higher Rate of Distant Metastases.
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they could be…
Interesting data published this week show HDC appears to benefit TNBC: https://mavendoctors…